What is the ROE (Return on Equity) of Orion Oyj this year?
The ROE of Orion Oyj this year is 0.24 undefined.
Orion Oyj ROE 2024
Orion Oyj ROE
0.24
Ticker
ORNBV.HE
ISIN
FI0009014377
WKN
A0J3QM
In 2024, Orion Oyj's return on equity (ROE) was 0.24, a -36.71% increase from the 0.38 ROE in the previous year.
Orion Oyj Aktienanalyse
What does Orion Oyj do?
Orion Oyj is a Finnish company that was founded in 1917 as a pharmacy in Turku. Today, Orion Oyj is a leading manufacturer of diagnostic tests, medicines, and other health products. Business model: Orion Oyj focuses on four core areas: Pharmaceutical, Diagnostics, Animal Health, and Fermion. The Pharmaceutical segment is the largest market and includes the production and sale of prescription drugs in the therapy areas of central nervous system disorders, oncology, respiratory diseases, and urology. Orion also produces generics of prescription drugs. The Diagnostics segment includes the development and production of in vitro diagnostic tests (IVDs) for clinical laboratories and point-of-care facilities. Animal Health manufactures products for animal health. Fermion produces active ingredients and intermediates for use in Orion's own and other pharmaceutical companies. Products: Orion offers a wide range of health products. The key products in the pharmaceutical segment are levodopa-based Parkinson's drugs (Stalevo, Comtess, and Opicapone) and drugs for the treatment of asthma and chronic obstructive pulmonary diseases (Easyhaler product family). ORIAHNN (Eligolix and estradiol capsules) was approved by the FDA as the first oral medication for the treatment of uterine fibroids in premenopausal women. In animal health, Orion Oyj offers products focused on the treatment of pet skin diseases, eye and ear infections, and parasite infestations. Orion also has a wide range of IVD products. The focus is on infection diagnostics, offering a wide range of medical tests to detect infections such as hepatitis B, hepatitis C, HIV, tuberculosis, human papillomavirus, and other sexually transmitted diseases. In the diagnostics segment, Orion also produces devices used in blood tests and other tests in hospitals and clinical laboratories. Future prospects: Orion Oyj is expected to invest more in the IVD segment in the coming years. The company sees significant growth potential here and plans to launch new products and test kits on the market. In addition, Orion also invests in spin-off companies focusing on the research and development of promising new technologies and therapies. Orion Oyj has been a leading player in the healthcare market for years. With a wide range of products and a strong focus on research and development, the company has built a solid foundation for future success. Orion Oyj ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROE Details
Decoding Orion Oyj's Return on Equity (ROE)
Orion Oyj's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.
Year-to-Year Comparison
Analyzing Orion Oyj's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.
Impact on Investments
Orion Oyj's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.
Interpreting ROE Fluctuations
Changes in Orion Oyj’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.
Frequently Asked Questions about Orion Oyj stock
How has the Return on Equity (ROE) of Orion Oyj developed compared to the previous year?
The ROE of Orion Oyj has increased by -36.71% decreased compared to the previous year.
What impact does a high ROE (Return on Equity) have on investors of Orion Oyj?
A high ROE indicates that Orion Oyj generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.
What impact does a low ROE (Return on Equity) have on investors of Orion Oyj?
A low ROE can indicate that Orion Oyj is having difficulties monetizing its investments successfully and can be a negative signal for investors.
How does a change in the ROE (Return on Equity) of Orion Oyj affect the company?
A change in ROE (Return on Equity) of Orion Oyj can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.
How to calculate the ROE (Return on Equity) of Orion Oyj?
The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.
Which factors influence the ROE (Return on Equity) of Orion Oyj?
Some factors that can influence Orion Oyj's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.
What strategic measures can take to improve the ROE (Return on Equity)?
To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.
How much dividend does Orion Oyj pay?
Over the past 12 months, Orion Oyj paid a dividend of 1.6 EUR . This corresponds to a dividend yield of about 3.26 %. For the coming 12 months, Orion Oyj is expected to pay a dividend of 1.73 EUR.
What is the dividend yield of Orion Oyj?
The current dividend yield of Orion Oyj is 3.26 %.
When does Orion Oyj pay dividends?
Orion Oyj pays a quarterly dividend. This is distributed in the months of April, April, April, November.
How secure is the dividend of Orion Oyj?
Orion Oyj paid dividends every year for the past 23 years.
What is the dividend of Orion Oyj?
For the upcoming 12 months, dividends amounting to 1.73 EUR are expected. This corresponds to a dividend yield of 3.54 %.
In which sector is Orion Oyj located?
Orion Oyj is assigned to the 'Health' sector.
Wann musste ich die Aktien von Orion Oyj kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Orion Oyj from 10/23/2024 amounting to 0.81 EUR, you needed to have the stock in your portfolio before the ex-date on 10/15/2024.
When did Orion Oyj pay the last dividend?
The last dividend was paid out on 10/23/2024.
What was the dividend of Orion Oyj in the year 2023?
In the year 2023, Orion Oyj distributed 1.5 EUR as dividends.
In which currency does Orion Oyj pay out the dividend?
The dividends of Orion Oyj are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Orion Oyj
Our stock analysis for Orion Oyj Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Orion Oyj Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
